Raleigh, NC, United States of America

Senthil Kumar Kusalakumari Sukumar

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Senthil Kumar Kusalakumari Sukumar: Innovator in Crystalline Compounds

Introduction

Senthil Kumar Kusalakumari Sukumar is a notable inventor based in Raleigh, NC (US). He has made significant contributions to the field of crystalline compounds, holding a total of 2 patents. His work focuses on the development of new crystalline forms that have potential applications in pharmaceuticals.

Latest Patents

One of his latest patents involves the creation of new crystals of (S)-N-[1-(4-fluorophenyl)ethyl]-4-(1-methyl-1H-pyrazol-4-yl)-N-(pyrazin-2-yl)pyridine-2,6-diamine maleate, referred to as 'compound A'. This patent describes a Form-I crystal of compound A, which exhibits specific diffraction peaks in its X-ray powder diffraction spectrum at various angles. Additionally, he has developed a Form-II crystal of the same compound, showcasing its unique diffraction characteristics. Another significant patent is for the ACH-0142684 sodium salt polymorph, which includes multiple polymorph forms and outlines their X-ray powder diffraction patterns.

Career Highlights

Throughout his career, Senthil has worked with prominent companies such as Achillion Pharmaceuticals, Inc. and Nippon Shinyaku Company, Ltd. His experience in these organizations has contributed to his expertise in the field of crystalline compounds and their applications in drug development.

Collaborations

Senthil has collaborated with notable professionals in his field, including Avinash S Phadke and Akihiro Hashimoto. These collaborations have further enhanced his research and development efforts in the area of crystalline compounds.

Conclusion

Senthil Kumar Kusalakumari Sukumar is a distinguished inventor whose work in crystalline compounds has the potential to impact the pharmaceutical industry significantly. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge and applications in this field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…